
Topic
Coverage Access
Formulary tiers, utilization management, patient support, and the access layer GoodRx and drug labels do not explain.

Pricing & Access· May 29, 2026 · 10 min read
By Ran Chen#HIV#Infectious Disease#Prior Authorization

Pricing & Access· May 29, 2026 · 10 min read
Tecentriq Hybreza bladder cancer MRD access guide
By Ran Chen#Oncology#PD-L1#Companion Diagnostic

Approvals· May 28, 2026 · 7 min read
Baxfendy coverage guide: baxdrostat access for uncontrolled hypertension
By Ran Chen#Hypertension#Cardiovascular#FDA Approval

Approvals· May 28, 2026 · 7 min read
Beqalzi coverage guide: sonrotoclax access in mantle cell lymphoma

Approvals· May 28, 2026 · 7 min read
Decnupaz coverage guide: pivekimab sunirine access in BPDCN

Biosimilars· May 27, 2026 · 9 min read
Actemra biosimilars access guide: IV vs SC routing and payer switching
By Ran Chen#Biosimilars#Immunology#HCPCS Coding

Pipeline· May 27, 2026 · 7 min read
Antibody-drug conjugate access landscape: ADC coverage and pipeline watch
By Ran Chen#ADC#HER2#Prior Authorization

Pricing & Access· May 27, 2026 · 10 min read
Cosentyx access guide: secukinumab coverage and benefit routing
By Ran Chen#Immunology#Prior Authorization#Payer Policy

Pricing & Access· May 27, 2026 · 12 min read
Enhertu coverage guide: HER2 testing, PA criteria, and patient support
By Ran Chen#Oncology#Prior Authorization#Payer Policy

Pricing & Access· May 27, 2026 · 11 min read
Entyvio access guide: IV vs SC vedolizumab coverage and IBD step therapy
By Ran Chen#Immunology#Prior Authorization#Payer Policy